159 related articles for article (PubMed ID: 36255176)
1. The clinicopathological and prognostic significances of CDC73 expression in breast cancer: A pathological and bioinformatics analysis.
E Y; Xue H; Zhang CY; Zhao MZ; Zheng HC
Histol Histopathol; 2023 Apr; 38(4):453-465. PubMed ID: 36255176
[TBL] [Abstract][Full Text] [Related]
2. The roles of the tumor suppressor parafibromin in cancer.
Zheng HC; Xue H; Zhang CY
Front Cell Dev Biol; 2022; 10():1006400. PubMed ID: 36211470
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.
Ciuffi S; Cianferotti L; Nesi G; Luzi E; Marini F; Giusti F; Zonefrati R; Gronchi G; Perigli G; Brandi ML
Endocr J; 2019 Apr; 66(4):319-327. PubMed ID: 30799315
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a new CDC73 missense mutation that impairs Parafibromin expression and nucleolar localization.
Masi G; Iacobone M; Sinigaglia A; Mantelli B; Pennelli G; Castagliuolo I; Palù G; Barzon L
PLoS One; 2014; 9(5):e97994. PubMed ID: 24842573
[TBL] [Abstract][Full Text] [Related]
5. Parafibromin expression in lung normal tissue and carcinoma: its comparison with clinicopathological parameters of carcinoma.
Xia P; Wang W; Xu XY; Wang JP; Takano Y; Zheng HC
Histol Histopathol; 2011 Aug; 26(8):1039-47. PubMed ID: 21692036
[TBL] [Abstract][Full Text] [Related]
6. Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features.
Gill AJ; Lim G; Cheung VKY; Andrici J; Perry-Keene JL; Paik J; Sioson L; Clarkson A; Sheen A; Luxford C; Elston MS; Meyer-Rochow GY; Nano MT; Kruijff S; Engelsman AF; Sywak M; Sidhu SB; Delbridge LW; Robinson BG; Marsh DJ; Toon CW; Chou A; Clifton-Bligh RJ
Am J Surg Pathol; 2019 Jan; 43(1):35-46. PubMed ID: 29324469
[TBL] [Abstract][Full Text] [Related]
7. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.
Newey PJ; Bowl MR; Cranston T; Thakker RV
Hum Mutat; 2010 Mar; 31(3):295-307. PubMed ID: 20052758
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological and prognostic significances of
Zheng HC; Gong BC; Zhao S
Oncotarget; 2017 Nov; 8(56):95270-95279. PubMed ID: 29221126
[TBL] [Abstract][Full Text] [Related]
9. A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome.
Chiofalo MG; Sparaneo A; Chetta M; Franco R; Baorda F; Cinque L; Granatiero M; D'Agruma L; Pezzullo L; Scillitani A; Guarnieri V
Cell Oncol (Dordr); 2014 Aug; 37(4):281-8. PubMed ID: 25113791
[TBL] [Abstract][Full Text] [Related]
10. Association Between Parafibromin Expression and Presence of Brown Tumors and Jaw Tumors in Patients with Primary Hyperparathyroidism: Series of Cases with Review of the Literature.
Popow M; Kaszczewska M; Góralska M; Kaszczewski P; Skwarek-Szewczyk A; Chudziński W; Jażdżewski K; Kolanowska M; Bogdańska M; Starzyńska-Kubicka A; Gałązka Z
Am J Case Rep; 2022 Oct; 23():e936135. PubMed ID: 36271606
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73.
Zhang JH; Panicker LM; Seigneur EM; Lin L; House CD; Morgan W; Chen WC; Mehta H; Haj-Ali M; Yu ZX; Simonds WF
Cell Death Differ; 2010 Oct; 17(10):1551-65. PubMed ID: 20339377
[TBL] [Abstract][Full Text] [Related]
12. Genotype of CDC73 germline mutation determines risk of parathyroid cancer.
Li Y; Zhang J; Adikaram PR; Welch J; Guan B; Weinstein LS; Chen H; Simonds WF
Endocr Relat Cancer; 2020 Sep; 27(9):483-494. PubMed ID: 32590342
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of parafibromin staining and CDC73 mutation in patients with parathyroid carcinoma: A systematic review and meta-analysis based on individual patient data.
Zhu R; Wang Z; Hu Y
Clin Endocrinol (Oxf); 2020 Apr; 92(4):295-302. PubMed ID: 31945198
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
15. Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family.
Guarnieri V; Seaberg RM; Kelly C; Jean Davidson M; Raphael S; Shuen AY; Baorda F; Palumbo O; Scillitani A; Hendy GN; Cole DEC
BMC Med Genet; 2017 Aug; 18(1):83. PubMed ID: 28774260
[TBL] [Abstract][Full Text] [Related]
16. The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy.
Shen DF; Liu X; Yang XF; Fang L; Gao Y; Zhao S; Wu JC; Shi S; Li JJ; Zhao XX; Gou WF; Zheng HC
Tumour Biol; 2016 Mar; 37(3):2909-24. PubMed ID: 26409451
[TBL] [Abstract][Full Text] [Related]
17. Para This, Fibromin That: The Role of CDC73 in Parathyroid Tumors and Familial Tumor Syndromes.
Ababneh E; Nosé V
Surg Pathol Clin; 2023 Mar; 16(1):97-105. PubMed ID: 36739170
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma.
Witteveen JE; Hamdy NA; Dekkers OM; Kievit J; van Wezel T; Teh BT; Romijn JA; Morreau H
Mod Pathol; 2011 May; 24(5):688-97. PubMed ID: 21240254
[TBL] [Abstract][Full Text] [Related]
19. The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers.
Zhang CY; Zhang L; Wang ZM; Ren DH; Zheng HC
J Obstet Gynaecol; 2023 Dec; 43(1):2213764. PubMed ID: 37218920
[TBL] [Abstract][Full Text] [Related]
20. A bioinformatics analysis of the clinicopathological and prognostic significance of
Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
